Cancer Research UK Therapeutic Discovery Laboratories, London Bioscience Innovation Centre, London, UK.
Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Methods Mol Biol. 2021;2263:423-446. doi: 10.1007/978-1-0716-1197-5_20.
A wide range of biological processes rely on complexes between ribonucleic acids (RNAs) and proteins. Determining the three-dimensional structures of RNA-protein complexes is crucial to elucidate the relationship between structure and biological function. X-ray crystallography represents the most widely used technique to characterize RNA-protein complexes at atomic resolution; however, determining their three-dimensional structures remains challenging. RNase contamination can ruin crystallization experiments by degrading RNA in complex with protein, leading to sample heterogeneity, and the conformational flexibility inherent in both protein and RNA can limit crystallizability. Furthermore, the three-dimensional structure can be difficult to accurately model at the typical diffraction limit of 2.5 Å resolution or lower for RNA-protein complex crystals. At this resolution, phosphates, which are electron dense, and bases, which are large, rigid, and planar, tend to be well resolved and easy to position in the electron density map, whereas other features, e.g., sugar atoms, can be difficult to accurately position. This chapter focuses on methods that can be used to overcome the unique problems faced when crystallizing RNA-protein complexes and determining their three-dimensional structures using X-ray crystallography.
广泛的生物过程依赖于核糖核酸 (RNA) 和蛋白质之间的复合物。确定 RNA-蛋白质复合物的三维结构对于阐明结构与生物功能之间的关系至关重要。X 射线晶体学是表征 RNA-蛋白质复合物在原子分辨率下的最广泛使用的技术; 然而,确定它们的三维结构仍然具有挑战性。核糖核酸酶污染会通过降解与蛋白质结合的 RNA 而破坏结晶实验,导致样品异质性,并且蛋白质和 RNA 固有的构象灵活性会限制结晶能力。此外,对于 RNA-蛋白质复合物晶体,三维结构可能难以在典型的衍射极限 2.5 Å 分辨率或更低的分辨率下准确建模。在该分辨率下,电子密度大的磷酸酯和大、刚性和平面的碱基往往能够很好地解析,并易于在电子密度图中定位,而其他特征,例如糖原子,则难以准确定位。本章重点介绍了在使用 X 射线晶体学结晶 RNA-蛋白质复合物并确定其三维结构时可以用来克服所面临的独特问题的方法。